when will generic tirzepatide be available FDA Accepts Sandoz Applications for Generic Mounjaro, Zepbound applications await

Hims & Hers launches a $49 compounded semaglutide pill for weight loss, drawing sharp criticism and legal threats from Novo Nordisk over safety and approval concerns.

For users this could segway into an expansion of the private market and for payers this could provide an affordable entry point for public reimbursement

SynZeal provides high-quality Setmelanotide Reference Standard, pharmacopeial and non-pharmacopeial impurities, degradants, and stable isotope products.

Key findings: 29% reduction in coronary heart disease death, myocardial infarction, or ischemic stroke (3-point MACE) 21% reduction in broader cardiovascular events including revascularization (4-point MACE) Median LDL-C reduced to 45 mg/dL versus 106 mg/dL with placebo Benefits were consistent regardless of concomitant GLP-1 receptor agonist or SGLT2 inhibitor use

Weight Loss Medication: Ozempic, Mounjaro, and Saxenda